| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.05 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.076 | 0.07 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |